The University of Virginia Cancer Center is conducting a clinical research study for patients who are adults ages 18 and over, and have advanced head and neck squamous cell carcinoma cancer. The purpose of this study to evaluate the combination of an experimental drug (VX-970) and chemotherapy (cisplatin) with radiation therapy in patients with advanced head and neck squamous cell carcinoma cancer. The study drug dose, safety, and effects of the experimental drug combination will be evaluated for this study. Participation is approximately 2 months of treatment, with an additional 3 months of frequent follow-up visits to keep track of how you are doing. A final 2-year follow-up visit will be done when you come in for your standard of care clinical visit. Study specific tests will be provided at no cost to you.
Additional information can be found here: https://clinicaltrials.gov/ct2/show/NCT02567422
You will not receive compensation for this study.